THBD and Sepsis: As for recombinant thrombomodulin, Eguchi et al. [16] reported that serious bleeding was recognized in 121 cases out of 1787 sepsis-induced DIC patients treated with recombinant thrombomodulin (6.8%) in their post-marketing survey.